| 产品详情 |
| Edit |   |
|---|
| Product Name | LDN-211904 |
|---|
| Description | Purity ~99% (HPLC). A pyrazolo[1,5-a]pyridine derivative that acts as an potent and reversible EphB3 receptor tyrosine kinase inhibitor with an IC50 of 79nM with good mouse liver microsomal stability and aqueous solubility. Shown to suppress EphB3-induced autophosphorylation of EphB3 receptor at 10uM in cells. When profiled against a panel of 288 kinases at 5uM, found to also inhibit most of the Eph (Erythropoietin-producing hepatocellular carcinoma) receptor kinases including EphA1, EphA2, EphA3, EphA4, EphA5, EphA8, EphB1, EphB2, EphB3, EphB4 and other tyrosine kinases, but not EphA6 and EphA7, and is non-inhibitory towards non-RTK kinases screened except for p38α, p38b, and Qik. Formula: C21H21ClN4O5 Molecular Weight: 444.9 Soluility: DMSO (50mg/ml, clear, nearly colorless solution) |
|---|
| Size | 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | LDN-211904 (N-(2-chlorophenyl)-6-(piperidin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide Ooxalate, EphB3 Inhibitor) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 217509 |
|---|
| Price | |
|---|
| Order / More Info | LDN-211904 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|